Quinagolide 1080 µg

DRUG2 trials

Sponsors

Ferring Pharmaceuticals

Conditions

EndometriosisEndometriosis-related Pain

Phase 2

Randomized Trial Assessing Quinagolide Vaginal Ring for Endometriosis-related Pain

CompletedNCT03692403

Ferring PharmaceuticalsEndometriosis-related Pain

Start: 2018-12-26End: 2022-02-14Updated: 2023-08-18

Quinagolide Vaginal Ring on Lesion Reduction Assessed by MRI in Women With Endometriosis/Adenomyosis

CompletedNCT03749109

Ferring PharmaceuticalsEndometriosis

Start: 2019-08-19End: 2021-07-18Updated: 2023-08-07

Related Papers

Quinagolide vaginal ring for reduction of endometriotic lesions: Results from the QLARITY trial.

2025-03-302 citations

O-021 Magnetic Resonance Imaging (MRI) evaluation of Quinagolide Vaginal Ring (QVR) treatment on endometrioma, Deep Infiltrating Endometriosis (DIE), and adenomyosis lesion characteristics: QLARITY trial results

Human Reproduction2024-07-01